Journal of Alzheimer s Disease · 2014 · 89 citations · 32 references
MedicineNeurologyNeuroscienceDementiaGeriatricsNeuropathologyAlzheimer DiseaseCerebrovascular DiseaseCognitive ImpairmentDementia Risk FactorsNeuroimaging In DementiaWhite Matter DisordersDementia-related Cognitive SymptomsJugular VeinsStructural MriWhite Matter AbnormalitiesWhite Matter ImagingWhite Matter InvolvementWhite Matter LesionsWhite Matter Pathology
To determine whether jugular venous reflux (JVR) is associated with cerebral white matter changes (WMCs) in individuals with Alzheimer's disease (AD), we studied 12 AD patients 24 mild cognitive impairment (MCI) patients, and 17 elderly age- and gender-matched controls. Duplex ultrasonography and 1.5T MRI scanning was applied to quantify cerebral WMCs [T2 white matter (WM) lesion and dirty-appearing-white-matter (DAWM)]. Subjects with severe JVR had more frequently hypertension (p = 0.044), more severe WMC, including increased total (p = 0.047) and periventricular DAWM volumes (p = 0.008), and a trend for increased cerebrospinal fluid volumes (p = 0.067) compared with the other groups. A significantly decreased (65.8%) periventricular DAWM volume (p = 0.01) in the JVR-positive AD individuals compared with their JVR-negative counterparts was detected. There was a trend for increased periventricular and subcortical T2 WMC lesion volumes in the JVR-positive AD individuals compared with their JVR-negative counterparts (p = 0.073). This phenomenon was not observed in either the control or MCI groups. In multiple regression analysis, the increased periventricular WMC lesion volume and decreased DAWM volume resulted in 85.7% sensitivity and 80% specificity for distinguishing between JVR-positive and JVR-negative AD patients. These JVR-WMC association patterns were not seen in the control and MCI groups. Therefore, this pilot study suggests that there may be an association between JVR and WMCs in AD patients, implying that cerebral venous outflow impairment might play a role in the dynamics of WMCs formation in AD patients, particularly in the periventricular regions. Further longitudinal studies are needed to confirm and validate our findings.
32
Clinical diagnosis of Alzheimer's disease
Guy M. McKhann, David A. Drachman, Marshall Folstein et al. · Neurology · 1984 · 28K citations · Full text
Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
Kwasi G. Mawuenyega, Wendy Sigurdson, Vitaliy Ovod et al. · Science · 2010 · 2.1K citations · Full text
Guy M. McKhann, David A. Drachman, Marshall Folstein et al. · Neurology · 2011 · 1.5K citations · Full text
Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD
Mitsuhiro Yoshita, Evan Fletcher, Danielle Harvey et al. · Neurology · 2006 · 445 citations
Medicine, Neurology, Neuroscience +17
Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS
Robert Zivadinov, Richard A. Rudick, Roberto De Masi et al. · Neurology · 2001 · 346 citations